AKT1 and leukemia: Furthermore, the application of NPs to prevent leukemia and cytotoxicity was evaluated by following the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway.